Point72 Asset Management L.P. purchased a new stake in Addus Homecare Co. (NASDAQ:ADUS) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 5,463 shares of the company’s stock, valued at approximately $383,000.
Several other institutional investors and hedge funds have also modified their holdings of the company. Bank of America Corp DE lifted its stake in shares of Addus Homecare by 240.4% in the 2nd quarter. Bank of America Corp DE now owns 5,878 shares of the company’s stock valued at $336,000 after purchasing an additional 4,151 shares during the period. WINTON GROUP Ltd bought a new stake in Addus Homecare in the 3rd quarter valued at about $509,000. Schwab Charles Investment Management Inc. increased its position in Addus Homecare by 30.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 16,279 shares of the company’s stock valued at $932,000 after buying an additional 3,779 shares in the last quarter. PEAK6 Investments LLC bought a new stake in Addus Homecare in the 3rd quarter valued at about $1,818,000. Finally, JPMorgan Chase & Co. increased its holdings in Addus Homecare by 4.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 172,791 shares of the company’s stock worth $12,121,000 after purchasing an additional 7,843 shares in the last quarter. Institutional investors own 92.93% of the company’s stock.
Addus Homecare stock traded down $1.37 during trading on Monday, hitting $63.59. The stock had a trading volume of 169,847 shares, compared to its average volume of 146,759. The company has a market cap of $832.92 million, a price-to-earnings ratio of 43.86, a PEG ratio of 1.86 and a beta of 0.02. Addus Homecare Co. has a 1 year low of $33.25 and a 1 year high of $77.82. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.37.
Addus Homecare (NASDAQ:ADUS) last posted its earnings results on Tuesday, November 6th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.08. Addus Homecare had a return on equity of 9.55% and a net margin of 3.25%. The firm had revenue of $137.63 million for the quarter, compared to the consensus estimate of $139.43 million. As a group, equities research analysts forecast that Addus Homecare Co. will post 1.68 earnings per share for the current fiscal year.
In related news, insider James Zoccoli sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $71.30, for a total transaction of $1,782,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider W Bradley Bickham sold 705 shares of the firm’s stock in a transaction that occurred on Thursday, January 17th. The shares were sold at an average price of $64.13, for a total transaction of $45,211.65. Following the sale, the insider now directly owns 21,010 shares of the company’s stock, valued at approximately $1,347,371.30. The disclosure for this sale can be found here. Insiders sold 924,105 shares of company stock valued at $66,981,062 over the last 90 days. 34.80% of the stock is currently owned by company insiders.
A number of brokerages have commented on ADUS. Zacks Investment Research raised Addus Homecare from a “strong sell” rating to a “hold” rating in a report on Friday, November 9th. BidaskClub lowered Addus Homecare from a “buy” rating to a “hold” rating in a report on Friday, January 11th. Oppenheimer boosted their target price on Addus Homecare from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 7th. Finally, Royal Bank of Canada began coverage on Addus Homecare in a research note on Monday, October 8th. They issued an “outperform” rating and a $81.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $75.38.
Addus Homecare Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company’s personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
See Also: Bid-Ask Spread
Receive News & Ratings for Addus Homecare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Addus Homecare and related companies with MarketBeat.com’s FREE daily email newsletter.